- Filed
- Mar 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 3, 2025 | 12.73M sh |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $17.07M |
| Cash And Equivalents | Q3 2025 · Apr 30, 2024 | $29.7M |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $34.9M |
| Current Liabilities | Q3 2025 · Apr 30, 2024 | $29.38M |
| Total Liabilities | Q3 2025 · Jan 31, 2025 | $67.2M |
| Total Liabilities | Q3 2025 · Apr 30, 2024 | $62.67M |
| Current Assets | Q3 2025 · Jan 31, 2025 | $168.03M |
| Current Assets | Q3 2025 · Apr 30, 2024 | $155.37M |
| Total Assets | Q3 2025 · Jan 31, 2025 | $245.88M |
| Total Assets | Q3 2025 · Apr 30, 2024 | $240.6M |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 12.88M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 13.03M sh |
| Stock Repurchased | Q3 2025 · Jan 31, 2024 | $5.55M |
| Capex | Q3 2025 · Jan 31, 2024 | $4.27M |
| Operating Cash Flow | Q3 2025 · Jan 31, 2024 | $9.82M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $182.43M |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $185.99M |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | $191.86M |
| Eps Diluted restated | Q3 2025 · Jan 31, 2024 | −$0.23 |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | −$0.53 |
| Eps Basic restated | Q3 2025 · Jan 31, 2024 | −$0.23 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | −$0.53 |
| Sga Expense | Q3 2025 · Jan 31, 2024 | $9.46M |
| Sga Expense | Q3 2025 · Jan 31, 2024 | $29.04M |
| Rd Expense | Q3 2025 · Jan 31, 2024 | $1.79M |
| Rd Expense | Q3 2025 · Jan 31, 2024 | $5.07M |
| Net Income | Q3 2025 · Jan 31, 2024 | −$2.91M |
| Net Income | Q3 2025 · Jan 31, 2024 | −$6.95M |
| Operating Income | Q3 2025 · Jan 31, 2024 | −$2.88M |
| Operating Income | Q3 2025 · Jan 31, 2024 | −$6.99M |
| Gross Profit | Q3 2025 · Jan 31, 2024 | $22.83M |
| Gross Profit | Q3 2025 · Jan 31, 2024 | $69.04M |
| Cost Of Revenue | Q3 2025 · Jan 31, 2024 | $30.59M |
| Cost Of Revenue | Q3 2025 · Jan 31, 2024 | $85.76M |
| Revenue | Q3 2025 · Jan 31, 2024 | $53.43M |
| Revenue | Q3 2025 · Jan 31, 2024 | $154.8M |